Press release
Emerging Lentiviral Vector Market Trend 2025-2034: Technological Advancements In Lentiviral Vector Production For Immuno-Oncology Therapies
Lentiviral Vector Market Size
The lentiviral vector market will grow from $14.37 billion in 2024 to $16.62 billion in 2025, at a CAGR of 15.7%. This market is expanding due to the growing prevalence of genetic disorders, increasing demand for gene delivery systems, biotech and pharmaceutical investments, and regulatory approvals for related therapies.
The lentiviral vector market is expected to grow to $29.41 billion by 2029, fueled by the rise of personalized medicine, gene editing, and demand for rare disease therapies. Trends include expansion in CAR-T therapy, vaccine development, and innovations in production technologies.
What Are the Key Drivers Behind the Growth of the Lentiviral Vector Market?
The growing prevalence of chronic diseases is expected to drive the growth of the lentiviral vectors market. Chronic diseases are long-term conditions that typically progress slowly and may persist for years or a lifetime. The prevalence of chronic diseases is rising due to aging populations, unhealthy lifestyles, urbanization, and environmental factors. Lentiviral vectors provide efficient tools for developing vaccines and treatments for chronic diseases, improving patient outcomes, and addressing unmet medical needs. For example, in September 2024, the British Heart Foundation reported that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with these conditions contributing to 27% of all deaths in the UK, resulting in over 170,000 deaths annually. As a result, the increasing prevalence of chronic diseases is driving the growth of the lentiviral vectors market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14742&type=smp
Who Are the Major Industry Players Fueling Lentiviral Vector Market Expansion?
Major companies operating in the lentiviral vector market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Agilent Technologies Inc., Amgen Inc., Merck KGaA, Lonza Group Ag, Cytiva, Charles River Laboratories, Bio-Rad Laboratories Inc., Promega Corporation, Takara Bio Inc., Sino Biological Inc., OriGene Technologies Inc., Applied Biological Materials Inc., Oxford Biomedica, Sirion-Biotech GmbH, Yposkesi
How Is the Lentiviral Vector Market Evolving?
In the lentiviral vectors market, major companies are advancing the development of LV vector production platforms like LentiSure to improve the efficiency and robustness of lentivirus vector production for immuno-oncology treatments. For example, in May 2023, Yposkesi sk pharmteco, a French company, launched LentiSure, a platform aimed at optimizing lentiviral vector production. This platform is designed to meet the increasing demand for efficient and scalable viral-vector manufacturing in cell and gene therapies. It ensures consistent product quality, with typical titers of 10e7 IG/mL per bioreactor volume, thus enhancing productivity for cell therapy developers.
How Is the Segmentation of the Lentiviral Vector Market Defined?
The lentiviral vector market covered in this report is segmented -
1) By Product Type: Kits, Reagents And Consumables
2) By Indication: Cancer, Genetic Disorder, Infectious Disease, Veterinary Disease, Other Indications
3) By End User: Biotechnology Companies, Pharmaceutical Companies, Contract Research Organization (CRO), Academic And Research Institutes
Subsegments:
1) By Kits: Lentiviral Transduction Kits, Lentiviral Packaging Kits, Lentiviral Vector Production Kits
2) By Reagents and Consumables: Lentiviral Packaging Reagents, Lentiviral Vector Concentration Reagents, Transfection Reagents for Lentiviral Vectors
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/lentiviral-vector-global-market-report
What Is the Leading Region in the Lentiviral Vector Market?
North America was the largest region in the lentiviral vector market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lentiviral vector market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Lentiviral Vector Global Market Report?
- Market Size Analysis: Analyze the Lentiviral Vector Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Lentiviral Vector Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Lentiviral Vector Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Lentiviral Vector Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Lentiviral Vector Market Trend 2025-2034: Technological Advancements In Lentiviral Vector Production For Immuno-Oncology Therapies here
News-ID: 3851460 • Views: …
More Releases from The Business Research Company
Tacrolimus Market Poised to Hit $8.68 Billion by 2029 with Accelerating Growth T …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Tacrolimus Market Size Growth Forecast: What to Expect by 2025?
The market size of tacrolimus has seen robust growth over the past few years. It is projected to increase from $6.59 billion in 2024 to $6.97 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. The…
Future of the Research-Grade Proteins Market: Strategic Analysis and Forecast to …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Research-Grade Proteins Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Recent years have seen a significant expansion in the market size for research-grade proteins. The market, which was valued at $1.11 billion in 2024, is projected to rise to $1.33 billion in 2025, marking a…
Key Trends Influencing the Growth of the Peptide Based Metabolic Disorders Thera …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Peptide Based Metabolic Disorders Therapeutics Market Through 2025?
The market size for therapeutics centered around peptide-based metabolic disorders has visibly expanded in the last few years. It is projected to escalate from $29.89 billion in 2024 to $34.1 billion in 2025, reflecting…
Oral Transmucosal Drugs: Core Growth Enabler in the Parkinson's Disease Driving …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Oral Transmucosal Drugs Industry Market Size Be by 2025?
Significant growth has been observed in recent years in the market for oral transmucosal drugs. The market, valued at $39.7 billion in 2024, is predicted to expand to $43.21 billion in 2025, with a compound annual growth…
More Releases for Lentiviral
Lentiviral Vector Market Size, Share, and Growth Opportunities 2023 -2030
This Lentiviral Vector Market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply…
Lentiviral Vector Market Overview: Segmentation, Outlook, and Trends Report 2033
The lentiviral vector market size has grown rapidly in recent years. It will grow from $12.50 billion in 2023 to $14.37 billion in 2024 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to prevalence of genetic disorders, gene delivery demand, biotech and pharma expansion, clinical trial investment, regulatory approvals.
The lentiviral vector market size is expected to see rapid growth…
Lentiviral Vectors Market Size 2024 to 2031.
Market Overview and Report Coverage
Lentiviral vectors are a type of viral vector used in gene therapy to deliver genetic material into target cells for both research and therapeutic purposes. These vectors are derived from lentiviruses, a type of retrovirus that can integrate their genetic material into the DNA of host cells.
The Lentiviral Vectors Market is poised for significant growth in the coming years, with a projected CAGR of…
The Lentiviral Vectors Market To Strive With Vertical Saas
Lentiviral vectors are gene delivery mechanisms that are produced from the lentivirus of the human immunodeficiency virus type 1 (HIV-1). These vectors are mainly incompetent for replication, and hence, regarded as generally safe. Yet, they can successfully integrate into the genomic DNA of a wide variety of dividing and non-dividing mammalian cell types.
With recorded sales of US$ 127.6 Mn in 2021, the global lentiviral vectors market is predicted to experience…
Lentiviral Vector Manufacturing Market Size
According to a new market research report published by Global Market Estimates, the Global Lentiviral Vector Manufacturing Market is projected to grow at a CAGR value of 17.8% from 2022 and 2027.
Charles River Laboratories, Vivebiotech, Thermo Fisher Scientific. Inc., GenScript, Creative Biogene, OriGene Technologies, Inc., Oxford Biomedica, Merck KGaA, Takara Bio, Pall Corporation, ITSBio Inc., ANDELYN BIOSCIENCES, Sino Biological Inc., Cellomics Technology, LLC, Virica Biotech, Cell Biolabs, Inc., SignaGen…
The Lentiviral Expression Systems Market to see through technological innovation …
Persistence Market Research, as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Lentiviral are vectors that are derived from the virus known as human immunodeficiency virus and is used to transfer gene in the cells, such as mammalian cell and others. Lentiviruses are used for transfection in…
